close android install prompt
Device Showcase
Download the app!
INSTALL
Evidence Central
  • Home
  • Favorites
  • Notes
  • Prime PubMed
  • Mobile
  • Browse
Log in
Refine your search:
35All Results
Evidence-Based Medicine GuidelinesEvidence-Based Medicine Guidelines
EE+ POEM ArchiveEE+ POEM Archive
Cochrane AbstractsCochrane Abstracts
BCG vaccine
35 results
1 - 35
  • EBMG BCG vaccine
    • Essentials
    • Vaccination
    • Normal vaccination reaction
    • Atypical vaccination reactions
      • Evidence Summaries
    • References
  • CochraneMVA85A vaccine to enhance BCG for preventing tuberculosis
    • Abstract
    • Reviewer's Conclusions
  • EBMG BCG vaccine in the prevention of tuberculosis
    • Evidence Summaries
    • References
  • EBMG Does the efficacy of BCG vaccine decline with time?
    • Evidence Summaries
    • References
  • EBMG Vaccines in alphabetical order
    • BCG, or tuberculosis vaccine
  • EBMG Vaccination against Mycobacterium leprae
    • Evidence Summaries
  • CochraneTreating BCG‐induced disease in children
    • Abstract
    • Reviewer's Conclusions
  • EBMG Vaccinations
    • Contraindications
    • Finnish national immunization programme
    • Vaccinations for special groups in the national immunization programme
      • Evidence Summaries
    • Vaccination techniques
  • EBMG List of abbreviations
    • Medical abbreviations
      • B
  • EBMG Organ transplant recipient in primary health care
    • Vaccinations
  • EBMG Treating BCG-induced disease in children
    • Evidence Summaries
  • CochraneInterventions for preventing infection in nephrotic syndrome
    • Abstract
    • Reviewer's Conclusions
  • EBMG Exposure to tuberculous infection
    • Examination of exposed persons
  • EBMG Physical examination of the newborn
    • History
  • CochraneIntravesical electromotive drug administration for non‐muscle invasive bladder cancer
    • Abstract
  • infoPOEMsEarly vaccinations not associated with celiac disease
    • Synopsis
  • CochraneWorkplace interventions to reduce the risk of SARS‐CoV‐2 infection outside of healthcare settings
    • Abstract
  • 1 - 35 of 35 records
Your free 1 year of online access expired  .

Want to regain access to Evidence Central?

Log in to Evidence Central

Note: Your username may be different from the email address used to register your account.

Contact Support

If you need further assistance, please contact Support.
  • unboundmedicine.com/support
  • support@unboundmedicine.com
  • 610-627-9090(Monday - Friday, 9 AM - 5 PM EST.)
Password reset sent
Username sent
Forgot your username or password?
Purchase Evidence Central
New to Evidence Central?
Visit the Unbound Medicine store
A Evidence Central subscription is required to
Already have an account?Log In
Purchase Evidence Central
New to Evidence Central?
Visit the Unbound Medicine store
Unbound Medicine logo
  • Home
  • Contact Us
  • Privacy / Disclaimer
  • Terms of Service
  • Log in
  • Cookie Preferences

© 2000–2026 Unbound Medicine, Inc. All rights reserved

CONNECT WITH US

facebookinstagramyoutubeLinkedIn

26.03.16-26.03.16_04